
Shares of healthcare conglomerate UnitedHealth UNH.N rise 2.1% to $476.85
A court-appointed special master has found that U.S. authorities lack evidence for their billion-dollar fraud case against UNH, which alleges the company kept overpayments from Medicare
Special Master Suzanne Segal's recommendation on Monday isn't final, but if U.S. District Judge Fernando Olguin adopts it, the DOJ's claims against the health insurer will be dismissed
Stock has fallen 3% in the past 12 months